INS and type 1 diabetes mellitus: Of note, adjunct agents to insulin in T1D may potentiate improvements in insulin sensitivity, supporting the reduction of insulin requirements, positively influencing weight loss, helping to regulate glucose control, reduce hypoglycemic events, exerting beneficial effects on cardiovascular risk factors, and even improving vascular damage.